Introduction: Genetic variations in DBH-gene and its surroundings have been shown to associate with smoking behavior including smoking cessation in several studies. In this study we replicate and measure the effect size for association between DBH polymorphism rs3025343 and smoking cessation in a large population-based sample while examining environmental factors that could relate to the association. Methods: We studied 11 926 adult subjects from four surveys of the National FINRISK Study. The analysis was restricted to either current or former smokers. Logistic and linear regression analyses were conducted to investigate the relationships of the single nucleotide polymorphism (SNP), covariates, smoking cessation, and smoking severity (cotinine, CPD). Gene-environment interactions were tested by likelihood-ratio test. Results: The association between rs3025343 and smoking cessation (prevalence odds ratio, OR = 1.12, p = .094, 95%CI = 0.98-1.30) was replicated identically with the GWAS study of The Tobacco and Genetics Consortium (OR = 1.12, 95%CI = 1.08-1.18). None of our tested phenotypes significantly influenced the association between rs3025343 and smoking cessation. Overall, marital status, education, depression, alcohol use, self-rated health, and chronic obstructive pulmonary disease (COPD) showed phenotypic associations with smoking cessation, but the association of various phenotypes with smoking cessation did not vary by genotype. Conclusions: The current study replicates the effect size for the association between rs3025343 and smoking cessation despite lack of overall significance due to smaller sample size. We could not show environmental influences on the association of rs3025343 with smoking cessation. Implications: Our study replicates the direction and strength of the association of DBH polymorphism rs3025343 with smoking cessation. We could not detect environmental influences on the strength of the association of rs3025343 with smoking cessation, but the limited power of our analysis needs to be taken into account.
Introduction
Quitting smoking is followed by immediate health benefits and a reduced risk of morbidity and mortality. Of the smokers that quit on their own only as few as 4%-7% do not lapse back to smoking within the first year. 1 Even when utilizing cessation treatments, only 15%-25% maintain abstinence for at least 1 year. 2 A better understanding of the genetic background of smoking cessation may provide the means to develop new and more efficient treatments, especially when the environmental factors are also taken into consideration. Heritable influences have been found for the ability to quit smoking. [3] [4] [5] [6] However, the evidence linking the best known single genetic variants to smoking cessation has been conflicting in observation studies and clinical trials. [7] [8] [9] Nicotine enhances dopamine release by activating dopaminergic neurons in the mesolimbic reward pathway, which is involved in feeling pleasure when smoking. The DBH-gene encodes dopamine β-hydroxylase, which catalyzes the conversion of dopamine to norepinephrine, and is also associated with smoking and drug dependencies.
The single nucleotide polymorphism (SNP) rs3025343, located 23 kb upstream of DBH, is associated with smoking cessation according to a very large GWAS meta-analysis. The study, which included 64 924 ever smokers (OR = 1.12, 95%CI = 1.08-1.18) found the G allele of rs3025343 to be more common among former than current smokers. 10 Another study with 3441 chronic obstructive pulmonary disease (COPD) patients of European ancestry replicated this association by demonstrating similar results (OR = 1.24, p = .015).
11 Both studies were observational. In a pooled analysis of two clinical trials reported by Leventhal and colleagues a haplotype of 6 DBH SNPs was found to predict abstinence at the end of cessation treatment and 6-month followup in study samples with high nicotine dependence. 12 Another study reported one DBH polymorphism to be associated with smoking severity among male schizophrenic smokers. 13 Although distinct from SNPs found significant in GWA studies, these findings support the hypothesis that DBH is an important candidate gene involved in smoking behavior.
Our aim was to replicate the result of GWAS regarding rs3025343 and its association with smoking cessation in a large population-based sample. Furthermore, analyses of the relationship between rs3025343 and environmental factors associated with smoking cessation were conducted in order to observe the influence of such environmental factors on the strength of the association of rs3025343 with smoking cessation. Analyses of per-allele associations were conducted using a random effects method.
Materials and Methods

Study Sample
Our sample was drawn from a Finnish population-based survey, the National FINRISK Study, which was first initiated in 1972 and has since then been carried out every 5 years using independent samples from four to six different parts of Finland depending on the year of survey. 14 We used data from cohorts 1992, 1997, 2002, and 2007, comprising of 26 582 genotyped persons with known smoking status. Our analysis focused on the 11 926 genotyped subjects (41% women) who were either current smokers (n = 6578) or had quit smoking at least 6 months prior to the survey (n = 5348). Other self-reported information about their health-related habits, socioeconomic status, and health status were obtained (see Supplementary Material for details on traits and genotyping). The mean age was 47.7 years (SD 12.7, range 25-74).
Statistical Analyses
For testing the associations between covariates and quitting smoking within different genotypes we combined AA and AG genotypes to get two genotype classes; AX and GG. This was done due to AA genotype being too rare to permit separate analyses as is visualized in Table 1 . We conducted logistic and linear regression analyses to investigate the relationships of the SNP, covariates, smoking cessation, and smoking severity. To examine whether the associations of the gene with outcome differed significantly by categories of covariates, we fit models with and without an interaction of the SNP and covariate, and tested the significance of the change in model fit using a likelihood ratio test to derive the significance of the interaction. Age, gender, region, and the year of questionnaire were adjusted in the analysis.
All statistical analyses were performed using Stata 13.1. 15 We report nominal p-values throughout the manuscript.
Results
The effect size (OR = 1.12, p = .094, 95%CI = 0.98-1.3) for association between rs3025343 and smoking cessation in the FINRISK study sample was replicated identically with the earlier GWA study (OR = 1.12, 95%CI = 1.08-1.18) although the association did not yield statistical significance. 10 This is shown in Table 1 together with genotype information of the study sample. Rs3025343 G allele was more abundant in Eastern Finland (North-Karelia and Northern Savo) than elsewhere. Allele frequencies were similar regardless of the survey year. Table 2 shows the results of the association analysis between smoking cessation and rs3025343 in different phenotypes. While variation in OR-values was observed within phenotype classes, the likelihood-ratio tests show that none of the gene-environment interactions exceeded statistical significance (p < .05). Thus, it appears that in this study, none of our tested phenotypes affects overall the strength of the association between rs3025343 and smoking cessation. Within variables, some individual categories showed nominally significant associations: among married persons (OR = 1.18, 95%CI 1.00-1.39), among those drinking 14 or more drinks weekly The logistic regression analysis of the rs3025343 genotypes on smoking cessation in different phenotypes examined the strength of the association between phenotype and smoking cessation within the main genotype classes (first two columns of results) and overall (last column) (Supplementary Table 1 ). The associations of phenotypes with smoking cessation were very similar in both genotype groups.
However, Supplementary Table 1 shows certain interesting results independent of genotype. Overall, having a diagnosis of bronchial asthma (OR = 1.19, 95%CI = 0.99-1.43) seems to make quitting smoking a little more probable while having COPD (OR = 0.55, 95%CI = 0.46-0.65) influences vice versa. Not surprisingly, quitting smoking is more likely for married people than singles, divorced or widowed. The same applies for high educated over low-educated people. Also, the better the self-rated health is, the greater the likelihood of having quit smoking.
Quitting was more likely for people who have never used medication for depression than for those who have (Supplementary  Table 1 ). Expectedly, alcohol consumption was also strongly related to smoking cessation; greater the alcohol use, the smaller the likelihood of having quit smoking. The effect is best seen in heavy drinkers (OR = 0.48) while abstainers comprise the reference group.
The rs3025343 allele did not affect cotinine levels (p = .78) nor CPD significantly (p = .21) among current smokers, that is, we find no influence of the variant on amount of smoking.
Discussion
Several studies have reported association between common variants and smoking cessation although most studies have shown only modest associations. Nevertheless, a large meta-analysis has shown significant association between one SNP, rs3025343 near DBH gene, and smoking cessation 10 and a second large meta-analysis, in African Americans, 16 showed nominal significance between rs3025343 and smoking cessation. This finding has been replicated among COPD-patients. 11 Moreover, a candidate gene study reported rs3025343 to be nominally associated with continuous Fagerström Test for Nicotine Dependence (FTND) score in European Americans (p = .023). 17 Based on present knowledge, FTND is one of the strongest predictors of smoking cessation. This indicates that rs3025343 may have an influence on the level of nicotine dependence and further, on smoking cessation. 17 Our study aimed to replicate the effect size for association between rs3025343 and smoking cessation that was reported in the meta-analysis of the Tobacco and Genetics Consortium. We also evaluated the roles and associations of different environmental factors in order to exclude their possible influence on the relationship between the SNP and smoking cessation. The effect size for the association between rs3025343 and smoking cessation was identical to that observed in the meta-analysis (OR = 1.12, p = .094, 95%CI = 0.98-1.3) although the association was not statistically significant in our study.
In addition to studies investigating association between rs3025343 and smoking cessation, diverse studies have been carried out about other polymorphisms near or within DBH-gene and their relation to smoking cessation, usually through nicotine dependence level. [18] [19] [20] [21] [22] Although their results appear somewhat inconsistent, these studies demonstrate the potential role of DBH in smoking-related behaviors. The key limitation of many studies concerning DBH and smoking cessation and main reason for insignificant results is small sample size since even modest genetic influences usually require large study samples to be detected. Many polymorphisms of DBH associated with smoking cessation may be in strong linkage disequilibrium with each other.
Rs3025343 does not cause a change in the amino acid residue in DBH since it is located in an intergenic region. Nevertheless, it could modify gene expression by affecting transcription either directly, through or together with other genetic variants in strong LD. The fact that only one DBH upstream variant (rs1611115) causes 51% of the variation in plasma-DBH activity in European-Americans strongly supports the conception that intergenic variants have a notable role in the regulation of gene expression. 23 Despite our relatively large total study sample size, minor allele carriers are rather few (7.1%). Thus, especially when inspecting disease phenotypes, the number of minor allele carriers becomes very small when examining different phenotypes within genotypes. This leads to the statistical power being too low (22% according to the power analysis) for demonstrating reliable conclusions regarding minor or major allele's specific influences on smoking cessation. This is the main limitation of our study. To increase power to 80%, as many as 36 092 cases and 29 343 controls would be required in total due to the low minor allele frequency. It should also be taken into account that we inspected and ruled out only a few carefully pre-selected covariates.
It is of interest that the DBH SNP has a different allelic distribution within Finland. The most probable explanation for the deviating allelic distribution is that the gene pool of people in Eastern and Western Finland are subject to influence from different regions together with the relatively small and regionally immobile population. Also, the role of that G allele on smoking cessation appeared to be more significant in North-Karelia (OR = 1.52, 95%CI = 1.05-2.21) than elsewhere, which can partly be due to the different allelic distribution. The regional distribution however did not affect our other results, as we adjusted for region in all analyses.
The current study replicates the effect size for the association between rs3025343 and smoking cessation although the association was not statistically significant. In addition we document associations of several covariates with smoking cessation.
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